Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study.
Children
Headache
Therapy program
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
25 Aug 2022
25 Aug 2022
Historique:
received:
16
06
2022
accepted:
15
08
2022
entrez:
25
8
2022
pubmed:
26
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
More than 2/3 of children and adolescents in Germany regularly suffer from headaches. Headache-related limitations in everyday life, school drop-out and educational impairment are common. Structured therapy programs for young headache patients are widely missing. One hundred eleven patients with frequent migraine and/or tension type headache were treated in a 15 hour group program in afternoons, parallel with school, parents received 7 hours of therapy. At the beginning of the program (T0), 6 (T1) and 12 months (T2) after completion, data on headache related disability (PedMidas), headache frequency, intensity, and pediatric pain disability score (PPDI) were prospectively collected to investigate the effects of the therapy. Seventy-five patients (9-19 years, median = 14; 66.7% female) and their parents provided patient reported outcome measures showing at T1 (65 patients) and T2 (47 patients) reduced headache frequency (last 3 months headache days median T0: 30 days; T1: 18 days, reduction of median 12 days since T0; T2: 13 days, reduction of median 17 days since T0). Linear mixed models revealed significant reduction (T0/T1 p = 0,002; T0/T2 p = 0,001). Reduced headache disability has been reported at T1 and T2 (PedMidas median T0 = 30, T1 = 15, T2 = 7; p < 0,001, p < 0,001 respectively). Follow up data of a subgroup of patients 24 months after the treatment point to sustainable effects. The interdisciplinary multimodal headache therapy program DreKiP reduces headache frequency and headache related disability significantly 6-12 months following its completion. DRKS00027523, retrospectively registered.
Sections du résumé
BACKGROUND
BACKGROUND
More than 2/3 of children and adolescents in Germany regularly suffer from headaches. Headache-related limitations in everyday life, school drop-out and educational impairment are common. Structured therapy programs for young headache patients are widely missing.
METHODS
METHODS
One hundred eleven patients with frequent migraine and/or tension type headache were treated in a 15 hour group program in afternoons, parallel with school, parents received 7 hours of therapy. At the beginning of the program (T0), 6 (T1) and 12 months (T2) after completion, data on headache related disability (PedMidas), headache frequency, intensity, and pediatric pain disability score (PPDI) were prospectively collected to investigate the effects of the therapy.
RESULTS
RESULTS
Seventy-five patients (9-19 years, median = 14; 66.7% female) and their parents provided patient reported outcome measures showing at T1 (65 patients) and T2 (47 patients) reduced headache frequency (last 3 months headache days median T0: 30 days; T1: 18 days, reduction of median 12 days since T0; T2: 13 days, reduction of median 17 days since T0). Linear mixed models revealed significant reduction (T0/T1 p = 0,002; T0/T2 p = 0,001). Reduced headache disability has been reported at T1 and T2 (PedMidas median T0 = 30, T1 = 15, T2 = 7; p < 0,001, p < 0,001 respectively). Follow up data of a subgroup of patients 24 months after the treatment point to sustainable effects.
CONCLUSIONS
CONCLUSIONS
The interdisciplinary multimodal headache therapy program DreKiP reduces headache frequency and headache related disability significantly 6-12 months following its completion.
TRIAL REGISTRATION
BACKGROUND
DRKS00027523, retrospectively registered.
Identifiants
pubmed: 36008766
doi: 10.1186/s10194-022-01481-1
pii: 10.1186/s10194-022-01481-1
pmc: PMC9404663
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109Informations de copyright
© 2022. The Author(s).
Références
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Curr Pain Headache Rep. 2015 Mar;19(3):4
pubmed: 25754597
Children (Basel). 2016 Nov 21;3(4):
pubmed: 27879631
Clin J Pain. 2018 Dec;34(12):1173-1179
pubmed: 30134282
Pain. 2014 Jan;155(1):118-128
pubmed: 24060708
Hamostaseologie. 2014;34 Suppl 1:S13-6
pubmed: 25382764
Pain. 1991 Sep;46(3):247-264
pubmed: 1758709
Curr Pain Headache Rep. 2020 Aug 25;24(10):62
pubmed: 32840694
Neurology. 2001 Dec 11;57(11):2034-9
pubmed: 11739822
Cephalalgia. 1997 Jun;17(4):488-91; discussion 487
pubmed: 9209767
Eur J Paediatr Neurol. 2011 May;15(3):234-40
pubmed: 21177128
Arch Pediatr Adolesc Med. 2005 Dec;159(12):1157-60
pubmed: 16330740
J Headache Pain. 2013 Jun 27;14:54
pubmed: 23806023
Neuropediatrics. 2013 Feb;44(1):20-4
pubmed: 23303552
J Pediatr. 2019 Feb;205:210-217
pubmed: 30384971
Pain. 2022 Feb 1;163(2):214-257
pubmed: 33863859
Neurology. 2019 Dec 10;93(24):e2224-e2236
pubmed: 31690685
Dtsch Arztebl Int. 2013 Nov 29;110(48):811-8
pubmed: 24333367
Clin J Pain. 2021 Jun 1;37(6):404-412
pubmed: 33859112
Pain. 2016 Oct;157(10):2152-2157
pubmed: 27152690
Psychosom Med. 2021 Sep 1;83(7):715-723
pubmed: 33951013
Cephalalgia. 1981 Jun;1(2):71-5
pubmed: 7346176
Headache. 2014 Jul-Aug;54(7):1194-202
pubmed: 24898739
J Headache Pain. 2010 Jun;11(3):215-25
pubmed: 20376520
Cephalalgia. 2019 Jul;39(8):1030-1040
pubmed: 30884960
Headache. 2009 Jul;49(7):990-1000
pubmed: 19473281
Pain. 2015 Nov;156(11):2212-2221
pubmed: 26172552
Schmerz. 2009 Feb;23(1):20-32
pubmed: 18941801
Schmerz. 2018 Feb;32(1):17-29
pubmed: 28956173
J Headache Pain. 2011 Aug;12(4):475-83
pubmed: 21544647
Headache. 2017 Mar;57(3):428-440
pubmed: 28127753
Eur J Neurol. 2015 Feb;22(2):270-6, e22
pubmed: 25244562
Disabil Rehabil. 2022 Jan;44(2):194-201
pubmed: 32406759
J Headache Pain. 2014 Feb 28;15:12
pubmed: 24580721
Neurology. 2017 Aug 1;89(5):461-468
pubmed: 28679597
Headache. 2016 Apr;56(4):711-6
pubmed: 26992129
Behav Sci (Basel). 2021 Apr 14;11(4):
pubmed: 33919881
J Headache Pain. 2018 Sep 4;19(1):79
pubmed: 30182167
Headache. 2018 Nov;58(10):1556-1567
pubmed: 30137650